Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $185,438 - $216,550
1,198 New
1,198 $205,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $178,604 - $201,151
1,298 New
1,298 $201,000
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $61,893 - $71,279
428 Added 21.79%
2,392 $381,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $39,694 - $47,604
-287 Reduced 12.75%
1,964 $317,000
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $78,647 - $90,202
-586 Reduced 20.66%
2,251 $302,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $64,681 - $82,231
-470 Reduced 14.21%
2,837 $426,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $86,710 - $107,583
-657 Reduced 16.57%
3,307 $536,000
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $71,440 - $90,393
-665 Reduced 14.37%
3,964 $537,000
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $563,920 - $640,134
-5,300 Reduced 53.38%
4,629 $499,000
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $92,479 - $103,027
-879 Reduced 8.13%
9,929 $1.12 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $550,271 - $605,782
5,379 Added 99.08%
10,808 $1.17 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $125,725 - $169,742
1,562 Added 40.39%
5,429 $582,000
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $6,450 - $9,779
100 Added 2.65%
3,867 $295,000
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $18,894 - $22,716
-300 Reduced 7.38%
3,767 $285,000
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $6,570 - $8,398
-100 Reduced 2.4%
4,067 $296,000
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $178,733 - $210,360
-2,317 Reduced 35.73%
4,167 $336,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $70,532 - $86,985
-906 Reduced 12.26%
6,484 $598,000
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $1.04 Million - $1.16 Million
-11,711 Reduced 61.31%
7,390 $699,000
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $1.21 Million - $1.43 Million
13,501 Added 241.09%
19,101 $1.77 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $515,256 - $689,976
5,600 New
5,600 $530,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sustainable Insight Capital Management, LLC Portfolio

Follow Sustainable Insight Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Insight Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Insight Capital Management, LLC with notifications on news.